Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Raw Materials (2019 - 2026)

Outset Medical has reported Raw Materials over the past 7 years, most recently at $27.2 million for Q4 2025.

  • Quarterly Raw Materials rose 5.76% to $27.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.2 million through Dec 2025, up 5.76% year-over-year, with the annual reading at $27.2 million for FY2025, 5.76% up from the prior year.
  • Raw Materials was $27.2 million for Q4 2025 at Outset Medical, up from $26.0 million in the prior quarter.
  • Over five years, Raw Materials peaked at $27.2 million in Q4 2025 and troughed at $10.9 million in Q1 2021.
  • The 5-year median for Raw Materials is $20.8 million (2022), against an average of $20.9 million.
  • Year-over-year, Raw Materials skyrocketed 150.93% in 2021 and then fell 9.3% in 2023.
  • A 5-year view of Raw Materials shows it stood at $18.1 million in 2021, then rose by 13.85% to $20.6 million in 2022, then decreased by 9.3% to $18.7 million in 2023, then surged by 37.41% to $25.7 million in 2024, then rose by 5.76% to $27.2 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Raw Materials are $27.2 million (Q4 2025), $26.0 million (Q3 2025), and $26.8 million (Q2 2025).